Light chain deposition disease (LCDD) results from a propensity of some human monoclonal L chains to form tissue deposits. We designed an experimental model for in vivo expression of human K L chain sequences in mice and compared a somatically mutated LCDD chain with a closely related control K chain, both encoded by the unique VKIV ONAMYLOID monoclonal Ig deposition disease (MIDD) is a severe complication of human immunoproliferative disorders, characterized by tissue deposition of monoclonal Ig chains, with a prominent kidney impairment.',' The occurrence of MIDD in myeloma is close to 5% of cases. MIDD deposits lack the staining properties and fibrillar organization of AL-amyloidosis, but exhibit granular material by electronmicroscopy. By immunofluorescence, an homogeneous staining is observed along basement membranes and in the glomerular mesangium. Deposits may contain only light (L) chain determinants in L chain deposition disease (LCDD), both L and heavy (H) chain determinants (LHCDD), or H chain determinants alone (HCDD)."4
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transfected Sp2/0 cells are thereafter called UT mice. Those injected with transfectoma clones producing either the LCDD FRA chain or the control K chain are called F and C mice, respectively. Mice were injected intravenously (into a tail vein) rather than intraperitoneally because the former procedure yielded retroperitoneal tumors and a longer survival than intraperitoneal tumors (mean, IO v 6 weeks).
Immunochemical studies. For Western blot, urine samples were collected just before the killing of the mice, analyzed by 12% sodium dodecyl sulfate-polyacrylamide gelelectrophoresis (a SDS-PAGE), transferred to nylon sheets, and shown with a biotinylated monoclonal antihuman K and streptavidin-alkaline phosphatase conjugate (Amersham, Buckinghamshire, UK). L chain secretion levels were measured in the serum by enzyme-linked immunosorbent assay (a ELISA), as described. 15 Human K chains were undetectable in UT mice but consistently detected in F and C mice. lmmunomorphologic studies. Light microscopic examination was performed after staining with hematoxylin and eosin, periodic acid Schiff, silver methenamine, or toluidine blue. Frozen blocks of all major organs obtained at killing of mice were cut in 4-pm-thick slices. Organs were studied for the deposition of human and mouse Ig by immunofluorescence with fluorescein-conjugated polyclonal rabbit antihuman-K or -X chain (Dako, Glostrup, Denmark) or with rabbit antimouse Ig-rhodamine conjugate (Jackson Immunoresearch, West Grove, PA).
Parts of the kidneys were stained with osmium for ultrastructural examination with a JEOL lOOCX electron microscope (Japan Electron Optical Laboratory, Tokyo, Japan).
Northern blot analysis. Total RNAs ( I O pg) from untransfected Sp2/0 cells, transfectomas, mice tumors, and the patient FRA's bone marrow were analyzed on 7% formaldehyde-1.2% agarose gels, transferred to nylon sheets, and hybridized with a probe corresponding to the FXA cDNA.'' Polymerase chain reaction (PCR) and sequence analysis. Total RNAs from F3, F7, and C9 mice tumors were studied by reverse transcription and PCR with a 5' primer corresponding to VKIV leader region (ATGGTGTTGCAGACCCAG) and a 3' primer complementary to the 3' untranslated region of CK (CTGGAACTGAGGAGC-AGGT).I6 PCR products were cloned and sequenced by the dideoxynucleotide method."
RESULTS
A high secretion rate of human K chains was obtained in vitro through transfection of Sp2/0 hybridoma cells with expression vectors carrying the sequences of either the LCDD K chain (FRA) or the control K chain. The LCDD K chain FRA was not glycosylated and its V region (residues 1 to 95) bore 14 aminoacid substitutions if compared with the single VKIV subgroup germline gene'0~'3~'8 (Fig 1) . The VKIV segment encoding the control chain differed from the germline by 3 substitution^'^ (Fig l) . In vivo production was obtained through injection of mice with either K chain FRA or control L chain transfectomas (F and C mice, respectively), but not with untransfected Sp2/0 cells (UT mice). Two groups of 12 F mice or 8 C mice were compared for secretion of K chains in the serum and formation of L chain deposits in the kidneys at death, 8 to 12 weeks after injection (Table 1) .
By immunofluorescence, human K chain determinants were readily detected along basement membranes in tumors and in every organ studied (kidney, liver, spleen, ovary, and heart) in 11 of 12 F mice (Fig 2B [kidney] and Fig 2C   Fig 1. Amino acid sequences of the LCDD chain (FRA) and the control K chain (C) produced in F and C mice, compared with the juxtaposed sequences encoded by the VKIV and JKI germline genes (GL).
[liver]), with a staining pattern very similar to that obtained in patient FRA (Fig 2A) . By contrast, no deposit was detected in any organ of the 8 C mice (Fig 2D) and 4 UT mice (data not shown). Lack of deposits in one F mouse (F3) likely related to its short survival after injection (5 weeks), whereas all other mice survived longer than 10 weeks. In C mice, small spots in kidney proximal cells indicated an internalization of the control chain (Fig 2D) , suggesting a normal reabsorption. Staining with the anti-h conjugate was negative in all mice (data not shown). By contrast to immunofluorescence, we were unable to detect any lesion or deposit in the kidneys from F, C, or UT mice by light and electron microscopy.
Identity of L chains produced in mice with the expected translation products of the expression vectors was checked at the mRNA and protein levels. Northern blotting of total RNAs from transfectomas grown in vitro or from tumors showed K mRNAs of the expected size in view of the splice sites used in the vectors (Fig 3) ." No human K mRNA was detected in UT mice tumors. Western blot of urines of F and C mice showed normal-sized chains (data not shown). The absence of any mutation in transfected genes during tumoral growth in mice was checked by sequencing K cDNAs from representative F (F3 and W ) and C (C9) mice (data not shown). For personal use only. on October 30, 2017. by guest www.bloodjournal.org From K chain from a patient with myeloma and LCDD had detectable deposits by immunofluorescence. Contrasting with immunofluorescence data, nodular glomerulosclerosis and lesions typical of MIDDL9 were undetectable by light or electron microscopy, which might also relate to the short survival of injected mice (10 to 12 weeks), andor to insufficient secretion rates. Indeed, in contrast to L chain-related primary amyloidosis," a significant plasma cell mass seems to be required for clinical expression of MIDD,' and in two patients in whom LCDD likely resulted from mutations induced by alkylating agents, the first symptoms of the disease occurred 8 and 12 months after chemotherapy, respectively.21322 The herein reported murine LCDD model thus likely mimics findings in certain human LCDD patients in whom the diagnosis of LCDD was based on functional alterations of the kidneys and typical LCDD staining by immunofluorescence, in the absence of detectable morphologic leoccurs later in the time course of the disease. F mice might then be of interest to study an early stage of LCDD of which they are representative.
L chains are of the K type in 80% of LCDD patients,' with a probable overrepresentation of the VKIV subgroup.14 Our data confirm that not all VKIV L chains are similarly prone to form deposits when present at similar concentrations; similarly to our control K chain, the KIV protein LEN that carried only one amino acid substitution by comparison to the germline VKIV did not yield any kidney deposition in the patient or when injected into mice.',' Our data also rule out any major role of the constant regions, which were identical in FRA and the control chain, and favor a role of the V regions. FRA and the control chain differ from the sequence encoded by the germline VKIV gene by 14 and 3 substitutions, respectively,lO," with most of them clustered in complementarity determining regions (CDR) and likely implying somatic mutations in the absence of allelic polymorphism of the VKIV gene." It thus appears that limited changes in the sequence of a K chain V domain promote deposition. Some peculiar substitutions such as Tyr32 -Cys in an outer part of the V domain corresponding to CDRl or Pro43 -Thr may specially affect the tertiary structure of the FRA V domain and change the interaction between L chain monomers or dimers or between L chains and the extracellular matrix proteins. Indeed, previous studies documented LCDD L chain V region peculiarities, including Nglycosylation,6 clustering of hydrophobic residues in regions exposed to s~l v e n t ,~~~~' ' and frequency of the VKIV subgroup.14 In another condition featuring tissue deposition of Ig chains, AL-amyloidosis, a role of V sequences is also suggested by the overrepresentation of the VAVI subgroup A chain^',^,^^ and by the high potential of dimerization observed in vitro for the variable domains of somatically mutated VKIV amyloidogenic L chain. 26 Altogether, these data show that (1) it is possible to obtain in mice L chain deposition resembling an initial step of human LCDD, (2) formation of deposits in LCDD is a property of the monoclonal L chain itself and does not result only from local tissue factors, and (3) amino acid changes in the V domain are sufficient to confer deposition properties to an L chain. Any definitive conclusion about the contribusions.7.23.24 A likely hypothesis is that glomerulosclerosis tion of given amino acid substitutions will need site-directed mutagenesis of the putative nephrotoxic substitutions. Towards that goal, the availability of a convenient experimental model is an important step towards a precise investigation of the structural abnormalities involved in the tissue deposition process.
